Literature DB >> 28962204

MicroRNA-421 promotes the proliferation and metastasis of gastric cancer cells by targeting claudin-11.

Peng Yang1, Mei Zhang2, Xiting Liu3, Huayun Pu2.   

Abstract

The present study aimed to evaluate the expression of microRNA (miR)-421 in gastric cancer and to investigate its biological function and underlying mechanism of action in the development of gastric cancer. The expression of miR-421 was measured in 60 pairs of clinically removed gastric cancer tissues and matched adjacent normal gastric tissues by reverse transcription-quantitative polymerase chain reaction. In addition, following transfection with an miR-421 inhibitor to suppress the expression of miR-421, the proliferation, migration and cell cycle distribution of human gastric carcinoma MKN28/MKN74 cells were determined by cell counting, Transwell and flow cytometry assays. The target gene of miR-421 was also predicted using bioinformatic analysis and verified by dual-luciferase reporter gene assay and western blot analysis. Furthermore, overexpression of the miR-421 target protein was induced in MKN28/MKN74 cells to determine its function. It was observed that miR-421 was significantly upregulated in gastric cancer tissues and that the expression of miR-421 was associated with lymph node metastasis and the clinical stage of gastric cancer (all P<0.05). Claudin11 (CLDN11) was predicted and verified as a direct target of miR-421. In vitro experiments demonstrated that inhibition of miR-421 expression suppressed the proliferation and metastasis of MKN28/MKN74 cells and induced G1/S-phase cell cycle arrest (all P<0.05). Analagous results were observed in MKN28/MKN74 cells following overexpression of the CLDN11 protein. Collectively, these data suggest that miR-421 may promote the proliferation, invasion and metastasis of gastric cancer by inhibiting the expression of CLDN11.

Entities:  

Keywords:  claudin-11; gastric cancer; metastasis; microRNA-421

Year:  2017        PMID: 28962204      PMCID: PMC5609270          DOI: 10.3892/etm.2017.4798

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  31 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Stomach development, stem cells and disease.

Authors:  Tae-Hee Kim; Ramesh A Shivdasani
Journal:  Development       Date:  2016-02-15       Impact factor: 6.868

3.  Contribution of microRNA-1275 to Claudin11 protein suppression via a polycomb-mediated silencing mechanism in human glioma stem-like cells.

Authors:  Keisuke Katsushima; Keiko Shinjo; Atsushi Natsume; Fumiharu Ohka; Makiko Fujii; Hirotaka Osada; Yoshitaka Sekido; Yutaka Kondo
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

Review 4.  Molecular characteristics of eight gastric cancer cell lines established in Japan.

Authors:  H Yokozaki
Journal:  Pathol Int       Date:  2000-10       Impact factor: 2.534

5.  MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.

Authors:  Jianhong Wu; Guangxin Li; Yongliang Yao; Zeyou Wang; Wangwei Sun; Jianjun Wang
Journal:  Biomarkers       Date:  2014-12-16       Impact factor: 2.658

6.  miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4.

Authors:  Liang Chen; Yanping Tang; Jian Wang; Zhongjie Yan; Ruxiang Xu
Journal:  Biochem Biophys Res Commun       Date:  2013-05-23       Impact factor: 3.575

7.  The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness.

Authors:  Denise Zwanziger; Julia Badziong; Saskia Ting; Lars Christian Moeller; Kurt Werner Schmid; Udo Siebolts; Claudia Wickenhauser; Henning Dralle; Dagmar Fuehrer
Journal:  Endocr Relat Cancer       Date:  2015-07-28       Impact factor: 5.678

8.  miR-485-5p acts as a negative regulator in gastric cancer progression by targeting flotillin-1.

Authors:  Min Kang; Mei-Ping Ren; Lei Zhao; Chang-Ping Li; Ming-Ming Deng
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

9.  15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer.

Authors:  Min Hu; Kai Li; Ninu Maskey; Zhigao Xu; ChunWei Peng; Sufang Tian; Yan Li; Guifang Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  DBD-F induces apoptosis in gastric cancer-derived cells through suppressing HIF2α expression.

Authors:  Guang-Hui Tong; Wei-Wei Tong; Xiao-Song Qin; Li-Ping Lu; Yong Liu
Journal:  Cell Oncol (Dordr)       Date:  2015-11-02       Impact factor: 6.730

View more
  13 in total

1.  Lidocaine inhibits cervical cancer cell proliferation and induces cell apoptosis by modulating the lncRNA-MEG3/miR-421/BTG1 pathway.

Authors:  Jinming Zhu; Shichao Han
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 2.  Claudins as biomarkers of differential diagnosis and prognosis of tumors.

Authors:  Olga P Popova; Alla V Kuznetsova; Svetlana Yu Bogomazova; Alexey A Ivanov
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-09       Impact factor: 4.553

3.  Upregulation of the APE1 and H2AX genes and miRNAs involved in DNA damage response and repair in gastric cancer.

Authors:  Fernanda S Manoel-Caetano; Ana Flávia T Rossi; Gabriela Calvet de Morais; Fábio Eduardo Severino; Ana Elizabete Silva
Journal:  Genes Dis       Date:  2019-04-05

Review 4.  Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.

Authors:  Tomasz M Grzywa; Klaudia Klicka; Paweł K Włodarski
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

Review 5.  Tight junction proteins in gastrointestinal and liver disease.

Authors:  Mirjam B Zeisel; Punita Dhawan; Thomas F Baumert
Journal:  Gut       Date:  2018-10-08       Impact factor: 31.793

6.  miRmapper: A Tool for Interpretation of miRNA⁻mRNA Interaction Networks.

Authors:  Willian A da Silveira; Ludivine Renaud; Jonathan Simpson; William B Glen; Edward S Hazard; Dongjun Chung; Gary Hardiman
Journal:  Genes (Basel)       Date:  2018-09-14       Impact factor: 4.096

7.  Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer.

Authors:  Yunxia Li; Xiaomei Cui; Yongdeng Li; Tingting Zhang; Shuyun Li
Journal:  Cancer Manag Res       Date:  2018-08-13       Impact factor: 3.989

8.  MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancer.

Authors:  Fu-Gang Duan; Mei-Fang Wang; Ya-Bing Cao; Run-Ze Li; Xing-Xing Fan; Imran Khan; Huan-Ling Lai; Yi-Zhong Zhang; Wendy Wen-Luan Hsiao; Xiao-Jun Yao; Qi-Biao Wu; Liang Liu; Yi-Jun Tang; Elaine Lai-Han Leung
Journal:  Cell Death Dis       Date:  2019-10-28       Impact factor: 8.469

9.  Characteristics of CXCL2 expression in coronary atherosclerosis and negative regulation by microRNA-421.

Authors:  Jun Yang; Hu Liu; Qian Cao; Wei Zhong
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

10.  Circular RNA circ_C16orf62 Suppresses Cell Growth in Gastric Cancer by miR-421/Tubulin beta-2A Chain (TUBB2A) Axis.

Authors:  Yanfeng Jin; Shanshan Zhang; Li Liu
Journal:  Med Sci Monit       Date:  2020-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.